Wuhan Xianlu Pharmaceutical Technology Competitors and Similar CompaniesClear all

Wuhan Xianlu Pharmaceutical Technology's competitors and similar companies include EUROAPI, Sirona Biochem, Laboratoires Expanscience and Cantabria Labs.

	Wuhan Xianlu Pharmaceutical Technology Wuhan Xianlu Pharmaceutical Technology (武汉先路医药科技股份有限公) is a producer and supplier of pharmaceutical products.	EUROAPI EUROAPI is a manufacturer and supplier of active pharmaceutical ingredients (APIs).	Sirona Biochem Sirona Biochem is a biotech company that develops the platform technology of fluorination chemistry.	Laboratoires Expanscience Laboratoires Expanscience is a pharmaceutical and dermo-cosmetics company.	Cantabria Labs Cantabria Labs (also known as Industrial Farmaceutica Cantabria) is a company specializing in dermatological prescriptions.
Founding Date	Founding Date 2010	Founding Date 2020	Founding Date 2009	Founding Date 1950	Founding Date 1989
Type	Type Private	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare chemicals clinical research cosmetics drug development pharma	Tags Healthcare chemicals clinical research drug development pharma	Tags Healthcare biotech chemicals cosmetics drug development pharma	Tags Healthcare clinical research cosmetics drug development pharma	Tags Healthcare clinical research cosmetics drug development pharma
Locations	Locations Wuhan, CN HQ	Locations Paris, FR HQ	Locations Vancouver, CA HQ	Locations Courbevoie, FR HQ	Locations Madrid, ES HQ
Employees	Employees N/A	Employees 3,187	Employees N/A	Employees 1,2441% increase	Employees 967
Valuation ($)	Valuation ($) N/A	Valuation ($) 368.2 m	Valuation ($) 9.3 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) €848.2m (FY, 2025)	Revenue (est.) $35k (FY, 2023)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods €645.6m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit €208.8m (FY, 2025)	Gross profit $35k (FY, 2023)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income (€211.1m) (FY, 2025)	Net income ($2.5m) (FY, 2023)	Net income N/A	Net income N/A